David E. Clements

4.5k total citations · 2 hit papers
28 papers, 3.6k citations indexed

About

David E. Clements is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, David E. Clements has authored 28 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 18 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in David E. Clements's work include Mosquito-borne diseases and control (20 papers), Viral Infections and Vectors (17 papers) and Viral Infections and Outbreaks Research (6 papers). David E. Clements is often cited by papers focused on Mosquito-borne diseases and control (20 papers), Viral Infections and Vectors (17 papers) and Viral Infections and Outbreaks Research (6 papers). David E. Clements collaborates with scholars based in United States, Netherlands and Italy. David E. Clements's co-authors include Steven Ogata, Yorgo Modis, Stephen C. Harrison, Beth-Ann Coller, Michael G. Rossmann, Ying Zhang, James H. Strauss, Timothy S. Baker, Wei Zhang and Richard Kühn and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

David E. Clements

27 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of the dengue virus envelope protein after membrane fusion

2004 918 citations Yorgo Modis, Steven Ogata et al. Nature profile →
A ligand-binding pocket in the dengue virus envelope glycoprotein

2003 851 citations Yorgo Modis, Steven Ogata et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Clements United States	20	3.0k	2.3k	587	507	408	28	3.6k
Shee‐Mei Lok Singapore	31	2.7k 0.9×	2.4k 1.0×	608 1.0×	502 1.0×	551 1.4×	51	3.6k
Steven Ogata United States	10	2.5k 0.8×	1.9k 0.8×	459 0.8×	448 0.9×	341 0.8×	10	2.9k
Thomas J. Chambers United States	22	2.6k 0.9×	2.0k 0.9×	526 0.9×	405 0.8×	252 0.6×	33	3.2k
Ricardo Galler Brazil	31	2.8k 0.9×	2.2k 1.0×	629 1.1×	439 0.9×	690 1.7×	81	4.0k
Steven L. Allison Austria	24	2.7k 0.9×	2.4k 1.0×	564 1.0×	551 1.1×	413 1.0×	28	3.4k
Kristen A. Bernard United States	36	3.2k 1.1×	3.0k 1.3×	440 0.7×	553 1.1×	367 0.9×	59	4.2k
Amadou A. Sall Senegal	39	3.1k 1.1×	3.2k 1.4×	528 0.9×	428 0.8×	385 0.9×	114	4.7k
Rebeca Rico-Hesse United States	27	3.6k 1.2×	3.2k 1.4×	476 0.8×	484 1.0×	252 0.6×	34	4.4k
Jorge L. Muñoz‐Jordán United States	38	4.2k 1.4×	3.5k 1.5×	837 1.4×	386 0.8×	482 1.2×	117	5.3k
Barry Falgout United States	25	2.3k 0.8×	1.6k 0.7×	285 0.5×	476 0.9×	425 1.0×	34	2.7k

Countries citing papers authored by David E. Clements

Since Specialization

Citations

This map shows the geographic impact of David E. Clements's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Clements with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Clements more than expected).

Fields of papers citing papers by David E. Clements

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Clements. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Clements. The network helps show where David E. Clements may publish in the future.

Co-authorship network of co-authors of David E. Clements

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Clements. A scholar is included among the top collaborators of David E. Clements based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Clements. David E. Clements is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nett, Randall J., Aaron C. Brault, Amy J. Lambert, et al.. (2025). Summary of human West Nile virus vaccine meeting, 2024: Investigating barriers to development. Vaccine. 68. 127938–127938.

Widen, Steven G., Jennifer K. Smith, Terry L. Juelich, et al.. (2023). Differences in Genetic Diversity of Mammalian Tick-Borne Flaviviruses. Viruses. 15(2). 281–281. 5 indexed citations

Lai, Chih-Yun, Teri Ann S. Wong, Michael M. Lieberman, et al.. (2021). Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice. Vaccine X. 9. 100126–100126. 14 indexed citations

Medina, Liana, Michael M. Lieberman, Teri Ann S. Wong, et al.. (2018). A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates. Frontiers in Immunology. 9. 2464–2464. 33 indexed citations

Lehrer, Axel T., Michael M. Lieberman, Tom Humphreys, et al.. (2017). Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice. Vaccine. 36(22). 3090–3100. 28 indexed citations

Hoeven, Neal Van, Angela M. Bosco‐Lauth, Christopher B. Fox, et al.. (2016). A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations. PLoS ONE. 11(2). e0149610–e0149610. 26 indexed citations

Manoff, Susan B., Sarah L. George, Andrew J. Bett, et al.. (2015). Preclinical and clinical development of a dengue recombinant subunit vaccine. Vaccine. 33(50). 7126–7134. 51 indexed citations

Govindarajan, Dhanasekaran, Liming Guan, David E. Clements, et al.. (2015). Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates. Vaccine. 33(33). 4105–4116. 59 indexed citations

Coller, Beth-Ann & David E. Clements. (2011). Dengue vaccines: progress and challenges. Current Opinion in Immunology. 23(3). 391–398. 101 indexed citations

10.

Pusic, Kae M., et al.. (2011). T Cell Epitope Regions of the P. falciparum MSP1-33 Critically Influence Immune Responses and In Vitro Efficacy of MSP1-42 Vaccines. PLoS ONE. 6(9). e24782–e24782. 13 indexed citations

11.

Coller, Beth-Ann, David E. Clements, Andrew J. Bett, Sangeetha L. Sagar, & Jan H. ter Meulen. (2011). The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease. Vaccine. 29(42). 7267–7275. 116 indexed citations

12.

Wong, Teri Ann S., et al.. (2006). Plasmodium falciparum: Immunization with MSP1-42 induced non-inhibitory antibodies that have no blocking activities but enhanced the potency of inhibitory anti-MSP1-42 antibodies. Experimental Parasitology. 115(4). 403–408. 1 indexed citations

13.

Lieberman, Michael M., David E. Clements, Steven Ogata, et al.. (2006). Preparation and immunogenic properties of a recombinant West Nile subunit vaccine. Vaccine. 25(3). 414–423. 59 indexed citations

14.

Watts, Douglas M., Robert B. Tesh, Marina Siirin, et al.. (2006). Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis. Vaccine. 25(15). 2913–2918. 35 indexed citations

15.

Putnak, J. Robert, Beth-Ann Coller, Gérald Voss, et al.. (2005). An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model. Vaccine. 23(35). 4442–4452. 130 indexed citations

16.

Modis, Yorgo, Steven Ogata, David E. Clements, & Stephen C. Harrison. (2004). Structure of the dengue virus envelope protein after membrane fusion. Nature. 427(6972). 313–319. 918 indexed citations breakdown →

17.

Zhang, Ying, Wei Zhang, Steven Ogata, et al.. (2004). Conformational Changes of the Flavivirus E Glycoprotein. Structure. 12(9). 1607–1618. 358 indexed citations

18.

Cuzzubbo, Andrea J., Timothy P. Endy, Ananda Nisalak, et al.. (2001). Use of Recombinant Envelope Proteins for Serological Diagnosis of Dengue Virus Infection in an Immunochromatographic Assay. Clinical and Diagnostic Laboratory Immunology. 8(6). 1150–1155. 88 indexed citations

19.

Watson, Barbara, Edward Rothstein, Hans‐Gert Bernstein, et al.. (1995). Safety and Cellular and Humoral Immune Responses of a Booster Dose of Varicella Vaccine 6 Years after Primary Immunization. The Journal of Infectious Diseases. 172(1). 217–219. 52 indexed citations

20.

Clements, David E., et al.. (1993). Multiple copies of a DNA sequence from Pseudomonas syringae pathovar phaseolicola abolish thermoregulation of phaseolotoxin production. Molecular Microbiology. 8(3). 625–635. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact